Patents by Inventor Robert Michael Saller

Robert Michael Saller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Non self-inactivating, expression targeted retroviral vectors
    Patent number: 7531353
    Abstract: The present invention relates to a retroviral vector undergoing promoter conversion comprising a 5?LTR region of the structure U3-R-U5; one or more sequences selected from coding and non-coding sequences; and a 3?LTR region comprising a completely or partially deleted U3 region wherein said deleted U3 region is replaced by a polylinker sequence, followed by the R and U5 region. The retroviral vector undergoes promoter conversion and is useful as a gene transfer vehicle for targeted gene therapy.
    Type: Grant
    Filed: February 28, 1997
    Date of Patent: May 12, 2009
    Assignee: GSF-Forschungszentrum fur Unwelt und Gesundheit GmbH
    Inventors: Walter Henry Günzburg, Robert Michael Saller
  • Encapsulated cells producing viral particles
    Patent number: 6776985
    Abstract: The present invention relates to encapsulated cells producing viral particles, especially retroviral particles containing the genome of a retroviral vector carrying therapeutic genes, to methods for the preparation of such encapsulated cells, as well as to the use of such encapsulated cells for the delivery of genes, especially therapeutic genes, to target organs/cells.
    Type: Grant
    Filed: December 23, 1997
    Date of Patent: August 17, 2004
    Assignees: Bavarian Nordic A/S, GSF-Gesellschaft fur Umwelt und Gesundheit GmbH
    Inventors: Robert Michael Saller, Walter H. Günzburg, Brian Salmons